Drug Profile
DNA-interleukin-2
Alternative Names: DNA-IL2Latest Information Update: 28 Oct 2018
Price :
$50
*
At a glance
- Originator Farmacore
- Class Cancer vaccines; DNA; DNA vaccines; Gene therapies
- Mechanism of Action Gene transference; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cervical cancer; Oropharyngeal cancer
Most Recent Events
- 28 Oct 2018 No recent reports of development identified for preclinical development in Cervical-cancer in Brazil (Parenteral)
- 28 Oct 2018 No recent reports of development identified for preclinical development in Oropharyngeal-cancer in Brazil (Parenteral)
- 30 Jun 2016 Preclinical development is ongoing in Brazil